DOI QR코드

DOI QR Code

D-dimer Analysis in Dogs With Hypercoagulable Diseases

  • Ku, Ta Liang (College of Veterinary Medicine, Chungnam National University) ;
  • Park, Hyung-Jin (College of Veterinary Medicine, Chungnam National University) ;
  • Seo, Kyoung-Won (College of Veterinary Medicine, Chungnam National University) ;
  • Song, Kun-Ho (College of Veterinary Medicine, Chungnam National University)
  • Received : 2017.07.27
  • Accepted : 2017.12.13
  • Published : 2017.12.31

Abstract

Total 283 dogs were enrolled in this study (control group: 140, patient group: 143). In the patient group, 143 dogs with underlying diseases including immune medicated hemolytic anemia (IMHA) (7), lymphoma (30), hyperadrenocorticism (HAC) (16), trauma (10), pyometra (8), bone fracture (38), peritonitis (13), meningoencephalitis (12) and mitral regurgitation (9) were enrolled in this study. Compared with healthy group, lymphoma, trauma, HAC, and IMHA group showed significantly (P < 0.01) high values of D-dimer and the highest levels in the IMHA group. Additionally, we evaluated the D-dimer level after a week of enoxaparin treatment, and the results showed D-dimer levels of post treatment group were significantly decreased compared to the pre-treatment group in lymphoma, HAC, trauma and IMHA diseases. In the high level D-dimer group, post D-dimer values after enoxaparin treatment had significantly decreased (P < 0.01) compared to levels prior to treatment.

Keywords

References

  1. Bedard C, Lanevschi-Pietersma A, Dunn M. Evaluation of coagulation markers in the plasma of healthy cats and cats with asymptomatic hypertrophic cardiomyopathy. Vet Clin Pathol 2007; 36: 167-172. https://doi.org/10.1111/j.1939-165X.2007.tb00203.x
  2. Epstein SE, Hopper K, Mellema MS, Johnson LR. Diagnostic utility of D-dimer concentrations in dogs with pulmonary embolism. J Vet Intern Med 2013; 27: 1649-1649.
  3. Griffin A, Callan MB, Shofer FS, Giger U. Evaluation of canine D-dimer point-of-care test kit for use in samples obtained from dogs with disseminated intravascular coagulation, thromboembolic disease, and hemorrhage. Am J Vet Res 2003; 64: 1562-1569. https://doi.org/10.2460/ajvr.2003.64.1562
  4. Goggs R, Benigni L, Fuentes VL, Chan DL. Pulmonary thromboembolism. J Vet Emerg Crit Care 2009; 19: 30-52. https://doi.org/10.1111/j.1476-4431.2009.00388.x
  5. Han L, Li QY, Zhou L, Wang X, Bao ZY, Li M, Wan HU, Shi GC. Effects of thrombolytic drugs and a selective endothelin-1 receptor antagonist on acute pulmonary thromboembolism in dogs. Chin Med J 2010; 123: 395-400.
  6. Harnett BE, Kerl ME. Unfractionated and low-molecularweight heparin for hypercoagulability in dogs and cats. Vet Med 2007; 102: 187-200.
  7. Monreal L. D-dimer as a new test for the diagnosis of DIC and thromboembolic disease. J Vet Intern Med 2003; 17: 757-759.
  8. New H, Byers CG. Pulmonary thromboembolism. Compend Contin Educ Vet 2011; 33: E1.
  9. Panek CM, Nakamura RK, Bianco D. Use of enoxaparin in dogs with primary immune-mediated hemolytic anemia: 21 cases. J Vet Emerg Crit Care 2015; 25: 273-277. https://doi.org/10.1111/vec.12286
  10. Weith JL. Low molecular weight heparins. N Engl J Med 1997; 337: 668-698.
  11. Williams MT, Aravindan N, Wallace MJ, Reidel BJCJ, Shaw ADS. Venous thrombosis in the intensive care unit. Crit Care Clin 2003; 19: 185-207. https://doi.org/10.1016/S0749-0704(02)00048-9